BMJ 347:f5934 OBrien PE et al (2019) Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding
PEPTIDE recovery BPC-157 Peptide therapy for tendon, ligament, muscle, and gut healing by consult
Liver function tests, lipid parameters, FBG, and HbA1c were reassessed at 6 months, while pancreatic enzyme levels were evaluated at baseline, 3 months, and 6 months
ABOUT SEMAGLUTIDE FOR WEIGHT LOSS Semaglutide is a GLP-1 medication originally used to treat type 2 diabetes, now FDA-approved for medical weight loss
Newer GLP-1 medications in development, including triple agonists that target GLP-1, GIP, and glucagon receptors, may offer even broader metabolic and anti-inflammatory effects